Study of Immunotherapy + Radiation in Soft Tissue CancerResearch Question:
What is the effect of immunotherapies with concurrent radiation followed by surgical
removal of soft tissue cancer?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The main aim of immunotherapy is to enable patients' immune system to target cancer
cells and destroy them. This study will treat patients with soft tissue sarcoma (cancer)
with neoadjuvant nivolumab and ipilimumab, antibodies that can be used as immunotherapies.
Patients will also receive concurrent radiation therapy. Following these treatments
will be the surgical removal of the patent's soft tissue sarcoma.
Study Reference #: USAR-17101
Lead Researcher (Principal Investigator)
Lead Researcher: Deepak Sahasrabudhe, MD
Study Contact InformationStudy Coordinator: Park Bogan
Phone: (585) 276-4415
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search